期刊
TRENDS IN MOLECULAR MEDICINE
卷 22, 期 1, 页码 53-67出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2015.11.001
关键词
-
资金
- US National Institutes of Health [AI075285, AI093903]
- National Multiple Sclerosis Society [RG4111A1, JF2161-A-5]
- International Progressive MS Alliance [PA0069]
- Regional Ministry of Economy, Science and Innovation [P11-CTS-8161]
- Regional Ministry of Health [PI13-575]
- PAIDI Program from the Andalusian Government [CTS-677]
- Spanish Ministry of Economy and Competitiveness
- FEDER [PI14-1600, 2012-39720, CP10-00527]
- CONACyT (Mexico)
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093903, K99AI075285, R01AI093903, R00AI075285] Funding Source: NIH RePORTER
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that primarily affects motor neurons and is accompanied by sustained unregulated immune responses, but without clear indications of the ultimate causative mechanisms. The identification of a diverse array of ALS phenotypes, a series of recently discovered mutations, and the links between ALS and frontotemporal degeneration have significantly increased our knowledge of the disease. In this review we discuss the main features involved in ALS pathophysiology in the context of recent advances in 'omics' approaches, including genomics, proteomics, and others. We emphasize the pressing need to combine clinical imaging with various different parameters taken from omics fields to facilitate early, accurate diagnosis and rational drug design in the treatment of ALS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据